Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page
- CheckyesterdayChange DetectedA sitewide NIH notice announces a website transition and says agencies are using “Super Intelligence” instead of “Artificial Intelligence.” It appears above the inaccessible study record.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s site revision identifier advanced from v3.7.1 to v3.7.2, while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0 on the 403 page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe study page now displays a 403 Forbidden error view instead of the study content, indicating the record is inaccessible. The page shows the 403 banner along with a Home link and site footer, signaling that the record cannot be accessed at this time.SummaryDifference21%

- Check57 days agoChange DetectedA new revision tag, Revision: v3.6.6, appears on the page, updating the revision history and replacing the previous Revision: v3.6.5.SummaryDifference0.0%

- Check79 days agoChange DetectedA new revision tag v3.6.5 appears, replacing v3.6.4, indicating an updated revision in the page metadata.SummaryDifference0.0%

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.